Paul J Kelly

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. doi Unexpected late radiation neurotoxicity following bevacizumab use: a case series
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street Asb1, L2, Boston, MA 02115, USA
    J Neurooncol 102:485-90. 2011
  2. doi Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 82:95-101. 2012
  3. doi Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    J Neurooncol 104:553-7. 2011
  4. doi Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases
    Michael A Dyer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 83:e479-86. 2012
  5. doi Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts, USA
    Cancer 118:2014-20. 2012
  6. doi Total dural irradiation: RapidArc versus static-field IMRT: a case study
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA, USA
    Med Dosim 37:175-81. 2012

Collaborators

Detail Information

Publications6

  1. doi Unexpected late radiation neurotoxicity following bevacizumab use: a case series
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women s Hospital, Harvard Medical School, 75 Francis Street Asb1, L2, Boston, MA 02115, USA
    J Neurooncol 102:485-90. 2011
    ..Phase III data on the safety and efficacy of bevacizumab use with radiation in the setting of glioblastoma is awaited...
  2. doi Stereotactic irradiation of the postoperative resection cavity for brain metastasis: a frameless linear accelerator-based case series and review of the technique
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 82:95-101. 2012
    ..We report our initial experience using an image-guided linear accelerator-based frameless stereotactic system and review the technical issues in applying this technique...
  3. doi Linear accelerator-based stereotactic radiosurgery for brainstem metastases: the Dana-Farber/Brigham and Women's Cancer Center experience
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    J Neurooncol 104:553-7. 2011
    ..6% at 1 year. RTOG grade 3 toxicities were recorded in two patients (ataxia, confusion). Linac-based SRS for small volume brainstem metastases using a median dose of 13 Gy is associated with acceptable local control and low morbidity...
  4. doi Importance of extracranial disease status and tumor subtype for patients undergoing radiosurgery for breast cancer brain metastases
    Michael A Dyer
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 83:e479-86. 2012
    ..In this retrospective study, we report on outcomes and prognostic factors for patients treated with stereotactic radiosurgery (SRS) for breast cancer brain metastases...
  5. doi Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Boston, Massachusetts, USA
    Cancer 118:2014-20. 2012
    ..The goal of this study was to analyze clinical outcomes and prognostic factors for survival in the salvage setting...
  6. doi Total dural irradiation: RapidArc versus static-field IMRT: a case study
    Paul J Kelly
    Department of Radiation Oncology, Dana Farber Brigham and Women s Cancer Center, Harvard Medical School, Boston, MA, USA
    Med Dosim 37:175-81. 2012
    ..Individualized collimator angle solutions should be considered by RapidArc dosimetrists for OARs dose reduction. RapidArc should be considered as a treatment modality for tumors that extensively involve in the skull, dura, or scalp...